This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...